Prophylaxis: The 'gold standard' treatment for haemophilia care
Haemophilia, a rare inherited bleeding disorder, causes excessive and spontaneous internal bleeding, leading to chronic disability and life-threatening situations. India faces a significant challenge with only 20% of estimated cases diagnosed due to lack of awareness and facilities, leaving many vulnerable. Untreated bleeds reduce life expectancy and cause socio-economic burdens. Prophylaxis, or regular replacement therapy of deficient clotting factors, has emerged as the 'gold standard' treatment. Unlike on-demand therapy, prophylaxis proactively prevents bleeds, ensuring good joint health, maintaining mobility, enhancing quality of life, and reducing healthcare burdens. Increased awareness and access to prophylaxis are critical to ending under-diagnosis and preventable disabilities in India.
Key Points
- Haemophilia is a rare inherited bleeding disorder causing excessive and spontaneous internal bleeding, leading to severe disability and life-threatening risks.
- India has a low diagnosis rate for haemophilia, with only 20% of estimated cases identified, due to lack of awareness and diagnostic facilities.
- Untreated haemophilia bleeds significantly reduce life expectancy and impose substantial socio-economic challenges.
- Prophylaxis, a proactive regular replacement therapy, is considered the 'gold standard' treatment, preventing bleeds and improving patient quality of life.
- Wider awareness and access to prophylaxis are crucial to address under-diagnosis and prevent disabilities in haemophilia patients in India.
Exam Facts
- Haemophilia is an inherited, rare bleeding disorder caused by a lack or deficiency of clotting factors, often Factor VIII.
- The prevalence of haemophilia is around 1 in 10,000.
- India has identified about 29,000 patients, which is 20% of estimated cases.
- Prophylaxis involves regular replacement therapy of deficient clotting factors.
Read it. Retain it. Recall it.
Get spaced-repetition flashcards, daily quizzes and offline access — free on Android.